Interestingly, it has recently been reported that the well-known disturbed pulsatility of insulin secretion in type 2 diabetes [36] is concomitant with disturbed glucagon pulsatility (higher pulse mass in patients with type 2 diabetes), possibly contributing to the hyperglucagonemia in these patients [37]. This evidence concerns the gene GCG and type 2 diabetes mellitus.